Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation strategies during elective percutaneous coronary angioplasty
2007-007142-36Phase 4Active
- Sponsor
- Centre Hospitalier de Pau
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of heparin, enoxaparin, bivalirudin, clopidogrel and aspirin in coronary arteriosclerosis (4 arms), sponsored by Centre Hospitalier de Pau. Primary endpoints: Ischemic risk and Bleeding risk. Started Feb 2008; status: active.
02
Drugs
heparinenoxaparinbivalirudinclopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-007142-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007142-36.